ESC 365 - Live panel discussion.

Open Access

Live panel discussion.

Session: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Topic: Risk Factors and Prevention

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

3 more presentations in this session

Glucagon-like peptide 1 receptor agonists & cardiovascular outcomes: What have we learned?

Speaker: Associate Professor M. Cavender (Chapel Hill, US)

Cardiovascular effects of glucagon-like peptide 1 receptor agonists.

Speaker: Doctor M. Husain (Toronto, CA)

Glucagon-like peptide 1 receptor agonist use in cardiology.

Speaker: Professor M. Petrie (Glasgow, GB)

Access the full session

Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists

Speakers: Associate Professor M. Cavender, Doctor M. Husain, Professor M. Petrie

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by